TY - JOUR
T1 - Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis
AU - Juárez-Rodríguez, María Dolores
AU - Yang, Jiseon
AU - Kader, Rebin
AU - Alamuri, Praveen
AU - Curtiss, Roy
AU - Clark-Curtiss, Josephine E.
PY - 2012/2
Y1 - 2012/2
N2 - Live recombinant attenuated Salmonella vaccine (RASV) strains have great potential to induce protective immunity against Mycobacterium tuberculosis by delivering M. tuberculosis antigens. Recently, we reported that, in orally immunized mice, RASV strains delivering the M. tuberculosis early secreted antigenic target 6-kDa (ESAT-6) protein and culture filtrate protein 10 (CFP-10) antigens via the Salmonella type III secretion system (SopE amino-terminal region residues 1 to 80 with two copies of ESAT-6 and one copy of CFP-10 [SopE Nt80-E2C]) afforded protection against aerosol challenge with M. tuberculosis. Here, we constructed and evaluated an improved Salmonella vaccine against M. tuberculosis. We constructed translational fusions for the synthesis of two copies of ESAT-6 plus CFP-10 fused to the OmpC signal sequence (OmpC SS-E2C) and amino acids 44 to 338 of antigen 85A (Ag85A 294) flanked by the signal sequence (SS) and C-terminal peptide (CT) ofβ-lactamase (Bla SS-Ag85A 294-Bla CT) to enable delivery via the Salmonella type II secretion system. The genes expressing these proteins were cloned as an operon transcribed from P trc into isogenic Asd +/MurA + pYA3681 lysis vector derivatives with different replication origins (pBR, p15A, pSC101), resulting in pYA4890, pYA4891, and pYA4892 for SopE Nt80-E2C/Ag85A 294 synthesis and pYA4893 and pYA4894 for OmpC SS-E2C/Ag85A 294 synthesis. Mice orally immunized with the RASV Χ11021 strain engineered to display regulated delayed lysis and regulated delayed antigen synthesis in vivo and harboring pYA4891, pYA4893, or pYA4894 elicited significantly greater humoral and cellular immune responses, and the RASV Χ11021 strain afforded a greater degree of protection against M. tuberculosis aerosol challenge in mice than RASVs harboring any other Asd +/MurA + lysis plasmid and immunization with M. bovis BCG, demonstrating that RASV strains displaying regulated delayed lysis with delayed antigen synthesis resulted in highly immunogenic delivery vectors for oral vaccination against M. tuberculosis infection.
AB - Live recombinant attenuated Salmonella vaccine (RASV) strains have great potential to induce protective immunity against Mycobacterium tuberculosis by delivering M. tuberculosis antigens. Recently, we reported that, in orally immunized mice, RASV strains delivering the M. tuberculosis early secreted antigenic target 6-kDa (ESAT-6) protein and culture filtrate protein 10 (CFP-10) antigens via the Salmonella type III secretion system (SopE amino-terminal region residues 1 to 80 with two copies of ESAT-6 and one copy of CFP-10 [SopE Nt80-E2C]) afforded protection against aerosol challenge with M. tuberculosis. Here, we constructed and evaluated an improved Salmonella vaccine against M. tuberculosis. We constructed translational fusions for the synthesis of two copies of ESAT-6 plus CFP-10 fused to the OmpC signal sequence (OmpC SS-E2C) and amino acids 44 to 338 of antigen 85A (Ag85A 294) flanked by the signal sequence (SS) and C-terminal peptide (CT) ofβ-lactamase (Bla SS-Ag85A 294-Bla CT) to enable delivery via the Salmonella type II secretion system. The genes expressing these proteins were cloned as an operon transcribed from P trc into isogenic Asd +/MurA + pYA3681 lysis vector derivatives with different replication origins (pBR, p15A, pSC101), resulting in pYA4890, pYA4891, and pYA4892 for SopE Nt80-E2C/Ag85A 294 synthesis and pYA4893 and pYA4894 for OmpC SS-E2C/Ag85A 294 synthesis. Mice orally immunized with the RASV Χ11021 strain engineered to display regulated delayed lysis and regulated delayed antigen synthesis in vivo and harboring pYA4891, pYA4893, or pYA4894 elicited significantly greater humoral and cellular immune responses, and the RASV Χ11021 strain afforded a greater degree of protection against M. tuberculosis aerosol challenge in mice than RASVs harboring any other Asd +/MurA + lysis plasmid and immunization with M. bovis BCG, demonstrating that RASV strains displaying regulated delayed lysis with delayed antigen synthesis resulted in highly immunogenic delivery vectors for oral vaccination against M. tuberculosis infection.
UR - http://www.scopus.com/inward/record.url?scp=84863145947&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863145947&partnerID=8YFLogxK
U2 - 10.1128/IAI.05526-11
DO - 10.1128/IAI.05526-11
M3 - Article
C2 - 22144485
AN - SCOPUS:84863145947
SN - 0019-9567
VL - 80
SP - 815
EP - 831
JO - Infection and immunity
JF - Infection and immunity
IS - 2
ER -